Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C S Probert

Showing results (81-90 of 84) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 84 results.
Gut|September 29, 2005
Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trialT N Brooklyn, M G S Dunnill, A Shetty, et al.
Journal of Breath Research|March 29, 2014
The use of a gas chromatograph coupled to a metal oxide sensor for rapid assessment of stool samples from irritable bowel syndrome and inflammatory bowel disease patientsS F Shepherd, N D McGuire, B P J de Lacy Costello, et al.
Biochimica Et Biophysica Acta|April 17, 2016
Unique microbial-derived volatile organic compounds in portal venous circulation in murine non-alcoholic fatty liver diseaseD T Reid, B McDonald, T Khalid, et al.
Alimentary Pharmacology & Therapeutics|March 5, 2013
Randomised clinical trial: once- vs. twice-daily prolonged-release mesalazine for active ulcerative colitisB Flourié, H Hagège, G Tucat, et al.
Pageof 9

Showing results (81-90 of 84) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 84 results.
Gut|September 29, 2005
Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trialT N Brooklyn, M G S Dunnill, A Shetty, et al.
Journal of Breath Research|March 29, 2014
The use of a gas chromatograph coupled to a metal oxide sensor for rapid assessment of stool samples from irritable bowel syndrome and inflammatory bowel disease patientsS F Shepherd, N D McGuire, B P J de Lacy Costello, et al.
Biochimica Et Biophysica Acta|April 17, 2016
Unique microbial-derived volatile organic compounds in portal venous circulation in murine non-alcoholic fatty liver diseaseD T Reid, B McDonald, T Khalid, et al.
Alimentary Pharmacology & Therapeutics|March 5, 2013
Randomised clinical trial: once- vs. twice-daily prolonged-release mesalazine for active ulcerative colitisB Flourié, H Hagège, G Tucat, et al.
Pageof 9